India, April 15 -- US-based Thermo Fisher Scientific Inc. has introduced theGibco CTS OpTmizer One Serum-Free Medium(CTS OpTmizer One SFM), a novel animal origin-free (AOF) formulation designed specifically for clinical and commercial cell therapy manufacturing to deliver increased scalability and performance of T-cell expansion. As a result, cell therapy manufacturers can use CTS OpTmizer One SFM to help optimise their workflows and get T-cell therapies to patients faster.

CTS OpTmizer One SFM's ready-to-use, one-part medium can help cell therapy manufacturers scale their manufacturing from process development to clinical trials and commercial manufacturing while maintaining consistent performance. As part of the cell expansion process,...